# Phase I/II Calcitriol in Lung Cancer

> **NCT00794547** · PHASE1,PHASE2 · TERMINATED · sponsor: **University of Michigan Rogel Cancer Center** · enrollment: 34 (actual)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **DRUG:** Calcitriol
- **DRUG:** Calcitriol

## Key facts

- **NCT ID:** NCT00794547
- **Lead sponsor:** University of Michigan Rogel Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-12
- **Primary completion:** 2011-10
- **Final completion:** 2013-08
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2017-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00794547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00794547, "Phase I/II Calcitriol in Lung Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00794547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*